Initiates Annual Revenue Guidance of $73 Million – $75 Million in Full Year 2023 BELGRADE, Mont. , May 04, 2023 (GLOBE NEWSWIRE) — Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today